0001127602-19-011406.txt : 20190314 0001127602-19-011406.hdr.sgml : 20190314 20190314185332 ACCESSION NUMBER: 0001127602-19-011406 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190314 FILED AS OF DATE: 20190314 DATE AS OF CHANGE: 20190314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANDINE MICHAEL J CENTRAL INDEX KEY: 0001235600 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 19682443 MAIL ADDRESS: STREET 1: 88 SIDNEY ST CITY: CAMBRIDGE STATE: MA ZIP: 021394136 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2019-03-14 0001520262 Alkermes plc. ALKS 0001235600 LANDINE MICHAEL J 852 WINTER ST. WALTHAM MA 02451 1 SVP, Corp Dev., Alkermes, Inc. Ordinary Shares 2019-03-14 4 M 0 25000 8.55 A 210122 D Ordinary Shares 2019-03-14 4 S 0 25000 33.0549 D 185122 D Employee Stock Option (Right to Buy) 8.55 2019-03-14 4 M 0 25000 0 D 2019-05-26 Ordinary Shares 25000 20000 D This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/18. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/18. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.87 to $33.53. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. These options are fully vested in accordance with their terms. /s/ Stephanie Roche, attorney-in-fact for Paul J. Mitchell 2019-03-14